Pay in 4 interest-free payments of $5.08 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
No head-to-head randomized controlled trial comparing Retatrutide vs Tirzepatide directly has been published as of 2026, making direct efficacy comparisons inferential based on cross-trial data
AstraZeneca is also looking at obesity as a potential driver of future revenues, with the $1.8 billion licensing deal for Eccogenes investigational GLP-1 receptor agonist for cardiometabolic diseases
Menopause Basics
Glutathione has a well-documented relationship with skin tone and brightness
US$ 22.71
US$ 22.39
US$ 26.27
US$ 27.45
US$ 21.56
US$ 28.47
US$ 29.35
